Aldeyra The (ALDX) Financials
ALDX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 66.5 trillion | 24.3 trillion |
| Dec. 31, 2025 | 72.1 million | 27.8 million |
| Sept. 30, 2025 | 77.8 million | 28.6 million |
| June 30, 2025 | 85.0 million | 29.7 million |
ALDX Free Cash Flow and Stock based compensation
No data available :(
ALDX Net Income
No data available :(
ALDX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 65.0 trillion | - | 212769 |
| Dec. 31, 2025 | 70.0 million | - | 280537 |
| Sept. 30, 2025 | 75.3 million | 72536 | 344484 |
| June 30, 2025 | 81.9 million | - | 406998 |
ALDX Shares Outstanding
ALDX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 2.4 million | 1.1 trillion | - |
| Dec. 31, 2025 | - | 4.3 million | 2.4 million | - |
| Sept. 30, 2025 | 4 | 5.4 million | 2.6 million | - |
| June 30, 2025 | - | 8.5 million | 1.7 million | - |
ALDX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 66599 |
| Dec. 31, 2025 | - | 65115 |
| Sept. 30, 2025 | - | 63683 |
| June 30, 2025 | - | 62282 |
ALDX
Price: $1.52
52 week price:
Earnings Per Share: -0.45 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 79624
Ebitda: -4.9 millionMarket Capitalization: 136.9 million